Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)
Title:
Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)
Author:
Koeberle, D. Betticher, D.C. von Moos, R. Dietrich, D. Brauchli, P. Baertschi, D. Matter, K. Winterhalder, R. Borner, M. Anchisi, S. Moosmann, P. Kollar, A. Saletti, P. Roth, A. Frueh, M. Kueng, M. Popescu, R.A. Schacher, S. Hess, V. Herrmann, R.